Repository logo
 

Systematic construction of progressively larger capsules from a fivefold linking pyrrole-based subcomponent

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Abstract

Biological encapsulants, such as viral capsids and ferritin protein cages, use many identical subunits to tile the surface of a polyhedron. Inspired by these natural systems, synthetic chemists have prepared artificial nanocages with well-defined shapes and cavities. Rational control over the self-assembly of discrete, nanometre-scale, hollow coordination cages composed of simple components remains challenging as a result of the entropic costs associated with binding many subunits together, difficulties in the error-correction processes associated with assembly and increasing surface energy as their size grows. Here we demonstrate the construction of nanocages of increasing size derived from a single pentatopic pyrrole-based subcomponent. Reasoned shifts in the preferred coordination number of the metal ions used, along with the denticity and steric hindrance of the ligands, enabled the generation of progressively larger cages. These structural changes of the cages are reminiscent of the differences in the folding of proteins caused by minor variations in their amino acid sequences; understanding how they affect capsule structure and thus cavity size may help to elucidate the construction principles for larger and functional capsules, capable of binding and carrying large biomolecules as cargoes.

Description

Journal Title

Nature Synthesis

Conference Name

Journal ISSN

2731-0582
2731-0582

Volume Title

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Engineering and Physical Sciences Research Council (EP/P027067/1)
European Research Council (695009)
This study was supported by the European Research Council (695009), the UK Engineering and Physical Sciences Research Council (EPSRC, EP/P027067/1) and Astex Therapeutics Ltd. (RG73357, Sustaining Innovation Postdoctoral Training Program – AH). We thank Diamond Light Source for providing time on Beamline I24.